期刊文献+

参苓白术散加减治疗结直肠癌术后泄泻临床效果观察 被引量:3

Clinical Effect Observation of Shenling Baizhu Decoction for the Treatment of Diarrhea after Colorectal Cancer Surgery
下载PDF
导出
摘要 目的:观察参苓白术散加减治疗结直肠癌术后泄泻的临床效果。方法:选取72例结直肠癌术后泄泻患者作为研究对象,将其分为西医组与中西医组,每组36例,西医组应用蒙脱石散联合双歧杆菌三联活菌肠溶胶囊治疗,中西医组在西医组的基础上应用参苓白术散加减治疗,对比两组患者的临床疗效。结果:中西医组总有效率是94.4%,明显高于西医组的77.8%,差异有统计学意义(X2=4.181,P<0.05);中西医组的体温复常时间、呕吐缓解时间、腹痛缓解时间、大便正常时间均短于西医组,差异有统计学意义(t=10.733、14.056、16.100、7.785,P<0.05);中西医组的IL-6、TNF-α水平均低于西医组,差异有统计学意义(t=6.156、7.159,P<0.05)。结论:参苓白术散加减治疗结直肠癌术后泄泻的临床效果满意,可快速缓解临床症状,降低炎症因子水平,值得推行。 Objective:To observe the clinical effect of Shenling Baizhusan Decoction for the treatment of diarrhea after colorectal cancer surgery.Method:72 patients with diarrhea after colorectal cancer surgery were selected as the research object,they were divided into the western medicine group and the traditional Chinese medicine and western medicine group,36 cases in each group,the western medicine group received the treatment of Montmorillonite Powder combined with Bifid Triple Viable Capsules Dissolving at intestines,the traditional Chinese and western medicine group received treatment of Shenling Baizhu Decoction on the basis of the western medicine group,the clinical effect were compared between the two groups.Result:The total efficiency in the traditional chinese medicine and western medicine group was 94.4%,significantly higher than 77.8%in the control group(X^2=4.181,P<0.05).The Body temperature recovery time,vomiting remission time,abdominal pain relief time,normal defecation time in traditional chinese medicine and western medicine group were shorter than the western medicine group(t=10.733,14.056,16.100,7.785,P<0.05).IL-6 and TNF-levels in traditional chinese medicine and western medicine group were lower than the western medicine group(t=6.156,7.159,P<0.05).Conclusion:The clinical effect of Shenling Baizhu Decoction for the treatment of diarrhea after colorectal cancer surgery satisfaction,can quickly relieve symptoms,reduce the level of inflammatory factors,worth pursuing.
作者 冯斌 FENG Bin(Fifth People’s Hospital of Wanzhou District in Chongqing City,Chongqing 404120,China)
出处 《中外医学研究》 2018年第20期26-28,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 参苓白术散 加减治疗 结直肠癌 泄泻 Shenling Baizhu Decoction Decoction treatment Colorectal cancer Diarrhea
  • 相关文献

参考文献11

二级参考文献94

  • 1丁维俊,周邦靖,翟慕东,白华.参苓白术散对小鼠脾虚模型肠道菌群的影响[J].北京中医药大学学报,2006,29(8):530-533. 被引量:118
  • 2周仲瑛.中医内科学[M].北京:中国中医药出版社,2008:415-416.
  • 3Cecil S,Chen P M,Callaway S E,et al.Traumatic brain injury:advanced multimodal neuromonitoring from theory to clinical practice.Crit Care Nurse,2011:31(2):25-36.
  • 4Cook A M,Peppard A,Magnuson B.Nutrition considerations in traumatic brain injury.Nutr Clin Pract,2009,23(6):608-620.
  • 5倪敏.脑肠轴的神经调节及治疗.中医肛肠理论与实践, 2007,13(2):93-95.
  • 6Lindsey K A,Brown R 0,Maish G 0,et al.Influence of traumatic brain injury on potassium and phosphorus homeostasis in critically ill multiple trauma patients.Nutrition,2010,26(7-8):784-790.
  • 7Koukourakis GV,Sotiropoulou LA. Targeted therapy with bevacizumab for metastatic colorectal cancer[J]. Clin Transl Oncol,2011,13(10) :710-714.
  • 8Katsumoto Y, Aritake N, Endoh A, et al. Three cases of pa- tients in their eighties who receive danti-EGFR antibody mono-therapy as first-line treatment for metastatic col orectal cancer[J]. GanTo Kagaku Ryoho,2013,38(12):2244- 2246.
  • 9Spath-Schwalbe E, Lange C,Genvresse I, et al. Influence of am-ifostine on toxicity of CHOP in elderly patients with aggressivenon-Hodgkin's lymphoma-a phase 11 study [J].Anticancer Drugs, 2002, 13 (4) : 395-403.
  • 10Shimada K,Ajani JA.Adjuvant therapy for gastric carci- nomapatients in the past 15 years:A review of western and orientahrials[J]. Cancer, 2012,86(9) : 1657-1668.

共引文献138

同被引文献45

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部